Advances in treating HER2-positive breast cancer: an interview with Sunil Verma.
Where this comes from
- Record sourced from PubMed, PMID 25285580.
- Also identified by DOI 10.1186/s12916-014-0129-y and PMC identifier PMC5125250.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this podcast, we talk to Dr Sunil Verma about the evolution of HER2 as a therapeutic target in breast cancer, and about how targeted therapy has revolutionized breast cancer treatment. We also discuss new agents in clinical development and the ways in which advances in treating HER2-positive breast cancer can be used to inform treatment decisions in other areas of medicine.